Publicaciones en colaboración con investigadores/as de Instituto Cajal (11)

2016

  1. Aldynoglia cells and modulation of RhoGTpase activity as useful tools for spinal cord injury repair

    Neural Regeneration Research, Vol. 11, Núm. 7, pp. 1043-1045

2015

  1. Inhibition of glial proliferation, promotion of axonal growth and myelin production by synthetic glycolipid: A new approach for spinal cord injury treatment

    Restorative Neurology and Neuroscience, Vol. 33, Núm. 6, pp. 895-910

2013

  1. Synthetic glycolipids for glioma growth inhibition developed from neurostatin and NF115 compound

    Bioorganic and Medicinal Chemistry Letters, Vol. 23, Núm. 2, pp. 435-439

2012

  1. Neural differentiation of transplanted neural stem cells in a rat model of striatal lacunar infarction: Light and electron microscopic observations

    Frontiers in Cellular Neuroscience, Vol. 6, Núm. AUG

2011

  1. Lipid and ganglioside alterations in tumor cells treated with antimitotic oleyl glycoside

    Molecular BioSystems, Vol. 7, Núm. 1, pp. 129-138

2009

  1. Detection of metabolite changes in C6 glioma cells cultured with antimitotic oleyl glycoside by1H MAS NMR

    Journal of Medicinal Chemistry, Vol. 52, Núm. 5, pp. 1263-1267

  2. Neurosphere cell differentiation to aldynoglia promoted by olfactory ensheathing cell conditioned medium

    GLIA, Vol. 57, Núm. 13, pp. 1393-1409

2007

  1. Design and synthesis of glycoside inhibitors of glioma and melanoma growth

    Journal of Medicinal Chemistry, Vol. 50, Núm. 2, pp. 364-373

2006

  1. Gelation under dynamic conditions: A strategy for in vitro cell ordering

    Journal of Materials Science: Materials in Medicine, Vol. 17, Núm. 9, pp. 795-802

  2. Regulation by GD3 of the proinflammatory response of microglia mediated by interleukin-15

    Journal of Neuroscience Research, Vol. 83, Núm. 5, pp. 754-762

2004

  1. Natural, synthetic and semisynthetic glycolipid inhibitors of glioma growth

    Expert Opinion on Therapeutic Patents, Vol. 14, Núm. 4, pp. 487-497